| | | | |
CUSIP No. 03940C 10 0 | | Schedule 13D/A | | Page 8 |
Item 1. Security and Issuer.
Item 1 of the Schedule 13D is hereby amended and supplemented as follows:
This Amendment No. 3 (this “Amendment No. 3”) to Schedule 13D amends and supplements the statements on the Schedule 13D originally filed with the SEC by the Reporting Persons on February 17, 2022, Amendment No. 1 filed with the SEC by the Reporting Persons on June 27, 2022, and Amendment No. 2 filed with the SEC by the Reporting Persons on May 19, 2023 (“Amendment No. 2”), relating to the common stock, $0.0001 par value per share (the “Common Stock”) of Arcellx, Inc., a Delaware corporation (the “Issuer”). The address of the Issuer’s principal executive offices is 25 West Watkins Mill Road, Suite A, Gaithersburg, Maryland 20878.
Certain terms used but not defined in this Amendment No. 3 have the meanings assigned thereto in the Schedule 13D (including Amendment No. 1 and Amendment No. 2 thereto). Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported on the Schedule 13D (including Amendment No. 1 and Amendment No. 2 thereto).
Item 3. Source and Amount of Funds or Other Consideration.
N/A. The Reporting Persons sold Common Stock.
Item 4. Purpose of Transaction.
The response set forth in Item 4 of the Schedule 13D is hereby supplemented as follows:
From May 31, 2023 to June 1, 2023, (1) SR One Fund I Aggregator LP (“Aggregator”) sold in the aggregate 340,720 shares of the Issuer’s Common Stock and (2) SR One Co-Invest II, LLC (“Co-Invest II”) sold in the aggregate 199,824 shares of the Issuer’s Common Stock (collectively, the “Transactions”). The Transactions were comprised of a block trade and various open market transactions at prices that ranged from $41.50 to $44.68 per share. Depending on market conditions, their continuing evaluation of the business and prospects of the Issuer and other factors, Aggregator, Co-Invest II and other Reporting Persons may dispose of or acquire additional shares of the Issuer.
Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in:
(a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;
(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;
(c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;
(d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;
(e) Any material change in the present capitalization or dividend policy of the Issuer;
(f) Any other material change in the Issuer’s business or corporate structure;
(g) Changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;
(h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;